Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.09 CAD
−5.06 M CAD
0.00 CAD
35.36 M
About THIOGENESIS THERAPEUTICS CORP
Sector
Industry
CEO
Patrice P. Rioux
Website
Headquarters
Toronto
Founded
2018
FIGI
BBG00PPXD1P0
Thiogenesis Therapeutics Corp. engages in developing novel drug formulations that act as precursors for rare diseases. The company was founded in 2018 and is headquartered in Toronto, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of TTI is 0.60 CAD — it hasn't changed in the past 24 hours. Watch THIOGENESIS THERAPEUTICS CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange THIOGENESIS THERAPEUTICS CORP stocks are traded under the ticker TTI.
TTI stock has risen by 3.45% compared to the previous week, the month change is a −11.76% fall, over the last year THIOGENESIS THERAPEUTICS CORP has showed a −17.81% decrease.
TTI stock is 3.33% volatile and has beta coefficient of −0.22. Track THIOGENESIS THERAPEUTICS CORP stock price on the chart and check out the list of the most volatile stocks — is THIOGENESIS THERAPEUTICS CORP there?
Today THIOGENESIS THERAPEUTICS CORP has the market capitalization of 26.43 M, it has decreased by −6.15% over the last week.
Yes, you can track THIOGENESIS THERAPEUTICS CORP financials in yearly and quarterly reports right on TradingView.
THIOGENESIS THERAPEUTICS CORP is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
TTI net income for the last quarter is −656.86 K CAD, while the quarter before that showed −651.32 K CAD of net income which accounts for −0.85% change. Track more THIOGENESIS THERAPEUTICS CORP financial stats to get the full picture.
No, TTI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TTI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade THIOGENESIS THERAPEUTICS CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So THIOGENESIS THERAPEUTICS CORP technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating THIOGENESIS THERAPEUTICS CORP stock shows the sell signal. See more of THIOGENESIS THERAPEUTICS CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.